Several countries have stopped administering the Moderna vaccine.
REPUBLIKA.CO.ID, JAKARTA — The US Food and Drug Administration (FDA) has said that the benefits of the Moderna Covid-19 vaccine outweigh the risks. This was disclosed because after some Nordic countries began to limit its use to certain age groups. Because, the country is worried about the side effects.
“The FDA is aware of these data. Currently, the FDA continues to find that the known and potential benefits of vaccination outweigh the known and potential risks for the Moderna Covid-19 vaccine,” an FDA official said. foxnews on Sunday (10/10).
Health officials in Finland have revealed that men under the age of 30 should not receive the Moderna vaccine because of a slightly higher risk of developing myocarditis, an inflammation of the heart. The day before, Sweden said it would temporarily suspend use of the Moderna vaccine for people under 30.
While Denmark is discontinuing use for people under 18 years of age and Norway is recommending people receive the Pfizer vaccine. The Nordic countries base their decisions on unpublished studies that will be reviewed by the European Medicines Agency. Sweden’s public health agency said the study found an increased risk of side effects such as inflammation of the heart muscle or pericardium although it noted the risk was very small.
The moderna Covid-19 vaccine and other versions have been shown to be safe and highly effective against the risk of hospitalization or death from the coronavirus. Moderna said he was aware of the very rare occurrence of myocarditis or pericarditis following the administration of the mRNA vaccine against Covid-19.
“These are usually mild cases and individuals tend to recover within a short time after standard care and rest. The risk of myocarditis increases substantially for those who contract Covid-19 and vaccination is the best way to protect against this,” he said.
The FDA granted full approval for Pfizer’s COVID-19 vaccine in August. Moderna’s application for full approval is pending.